(CBMG) |
| 0 (0%) 08-30 16:03 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 45.66 |
| Resistance 1: | 39.09 |
| Pivot price: | 35.00 |
| Support 1: | 34.49 |
| Support 2: | 31.64 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 1.080 |
| Book Value | 1.740 |
| PEG Ratio | 1.99 |
| Gross Profit | 3.850 |
| Profit Margin (%) | 11.43 |
| Operating Margin (%) | 16.11 |
| Return on Assets (ttm) | 13.1 |
| Return on Equity (ttm) | 49.6 |
Company news
Mon, 20 Nov 2023
CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. - PR Newswire
Thu, 04 May 2023
Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies - PMLiVE
Thu, 04 May 2023
J&J forks out $245m to develop CAR-T therapies - BioProcess International
Tue, 02 May 2023
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies - BioSpace
Wed, 12 Jan 2022
FDA Grants Regenerative Medicine Advanced Therapy and Fast Track Designations to C-CAR039 for Relapsed/Refractory DLBCL - CancerNetwork
Wed, 12 Jan 2022
FDA Grants RMAT/Fast Track Designations to C-CAR039 for Relapsed/Refractory DLBCL - OncLive
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
